Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: Sample size considerations for clinical trials

Journal of Cardiovascular Magnetic Resonance

Volumn 14, Issue 1, 2012, Pages

  Liu, Songtao ^a,b   Han, Jing ^c   Nacif, Marcelo S ^a,b   Jones, Jacquin ^a   Kawel, Nadine ^a   Kellman, Peter ^d   Sibley, Christopher T ^a,b   Bluemke, David A ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE MEGLUMINE; CONTRAST MEDIUM; GADOBENIC ACID; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ADULT; ARTICLE; BLOOD; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART MUSCLE; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; REPRODUCIBILITY; AGED; ANALOGS AND DERIVATIVES; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; CLINICAL TRIAL (TOPIC); DIAGNOSTIC USE; FIBROSIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; SAMPLE SIZE; TIME; YOUNG ADULT;

ADULT; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CLINICAL TRIALS AS TOPIC; CONTRAST MEDIA; FEMALE; FIBROSIS; HEART FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SAMPLE SIZE; TIME FACTORS; YOUNG ADULT;

EID: 84872914836     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-14-90     Document Type: Article

References (47)

1. Dilated cardiomyopathy is associated with an increase in the type I/type III collagen ratio: a quantitative assessment. Marijianowski MM, Teeling P, Mann J, Becker AE, J Am Coll Cardiol 1995 25 1263 1272 10.1016/0735-1097(94)00557-7 7722119
2. Age related changes of the collagen network of the human heart. Gazoti Debessa CR, Mesiano Maifrino LB, de Mesiano Maifrino LB, Mech Ageing Dev 2001 122 1049 1058 10.1016/S0047-6374(01)00238-X 11389923 (Pubitemid 32520990)
3. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA, J Am Coll Cardiol 2011 57 891 903 10.1016/j.jacc.2010.11.013 21329834
4. Interstitial fibrosis in the dilated non-ischaemic myocardium. Brooks A, Schinde V, Bateman AC, Gallagher PJ, Heart 2003 89 1255 1256 10.1136/heart.89.10.1255 12975439 (Pubitemid 37164032)
5. Heart failure with preserved ejection fraction. Udelson JE, Circulation 2011 124 540 e543 10.1161/CIRCULATIONAHA.111.071696 22105201
6. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, Starling RC, Towbin J, Virmani R, J Am Coll Cardiol 2007 50 1914 1931 10.1016/j.jacc.2007.09.008 17980265 (Pubitemid 350011209)
7. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ, J Am Coll Cardiol 2008 52 1574 1580 10.1016/j.jacc.2008.06.049 19007595
8. The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Pereira RS, Prato FS, Wisenberg G, Sykes J, Magn Reson Med 1996 36 684 693 10.1002/mrm.1910360506 8916018 (Pubitemid 26376706)
9. Assessment of myocardial viability using MRI during a constant infusion of Gd-DTPA: further studies at early and late periods of reperfusion. Pereira RS, Prato FS, Sykes J, Wisenberg G, Magn Reson Med 1999 42 60 68 10.1002/(SICI)1522-2594(199907)42:1<60::AID-MRM10>3.0.CO;2-9 10398951 (Pubitemid 29325614)
10. T1 Mapping in Cardiomyopathy by Cardiac Magnetic Resonance: Comparision to Endomyocardial Biopsy. Sibley CT, Noureldin RA, Gai N, Nacif MS, Liu S, Turkbey EB, Mudd JO, Lima JA, Halushka MK, Bluemke DA, Radiology 2012 In Press
11. Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study. Sparrow P, Messroghli DR, Reid S, Ridgway JP, Bainbridge G, Sivananthan MU, AJR Am J Roentgenol 2006 187 630 W635 10.2214/AJR.05.1264 17114517
12. Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis. Preliminary Validation in Humans. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC, Circulation 2010 122 138 144 10.1161/CIRCULATIONAHA.109.930636 20585010
13. Quantification of Diffuse Myocardial Fibrosis and its Association with Myocardial Dysfunction in Congenital Heart Disease. Broberg CS, Chugh S, Conklin C, Sahn DJ, Jerosch-Herold M, Circ Cardiovasc Imaging 2010 3 727 734 10.1161/CIRCIMAGING.108.842096 20855860
14. T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison. Gai N, Turkbey EB, Nazarian S, van der Geest RJ, Liu CY, Lima JA, Bluemke DA, Magnetic resonance in medicine: official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2011 65 1407 1415 10.1002/mrm.22716
15. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Ugander M, Oki AJ, Hsu LY, Kellman P, Greiser A, Aletras AH, Sibley CT, Chen MY, Bandettini WP, Arai AE, Eur Heart J 2012 33 1268 1278 10.1093/eurheartj/ehr481 22279111
16. Interstitial Myocardial Fibrosis Assessed as Extracellular Volume Fraction with Low-Radiation-Dose Cardiac CT. Nacif MS, Kawel N, Lee JJ, Chen X, Yao J, Zavodni A, Sibley CT, Lima JA, Liu S, Bluemke DA, Radiology 2012 264 876 883 10.1148/radiol.12112458 22771879
17. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Sado DM, Flett AS, Banypersad SM, White SK, Maestrini V, Quarta G, Lachmann RH, Murphy E, Mehta A, Hughes DA, et al. Heart 2012 98 1436 1441 10.1136/heartjnl-2012-302346 22936681
18. Quantification of Extracellular Matrix Expansion by CMR in Infiltrative Heart Disease. Mongeon FP, Jerosch-Herold M, Coelho-Filho OR, Blankstein R, Falk RH, Kwong RY, JACC Cardiovasc Imaging 2012 5 897 907 10.1016/j.jcmg.2012.04.006 22974802
19. Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. Schelbert EB, Testa SM, Meier CG, Ceyrolles WJ, Levenson JE, Blair AJ, Kellman P, Jones BL, Ludwig DR, Schwartzman D, et al. J Cardiovasc Magn Reson 2011 13 16 10.1186/1532-429X-13-16 21375743
20. Myocardial T1 and extracellular volume fraction mapping at 3 tesla. Lee JJ, Liu S, Nacif MS, Ugander M, Han J, Kawel N, Sibley CT, Kellman P, Arai AE, Bluemke DA, J Cardiovasc Magn Reson 2011 13 75 10.1186/1532-429X-13-75 22123333
21. T1 mapping of the myocardium: Intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region. Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA, J Cardiovasc Magn Reson 2012 14 27 10.1186/1532-429X-14-27 22548832
22. Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms. Lombardi R, Rodriguez G, Chen SN, Ripplinger CM, Li W, Chen J, Willerson JT, Betocchi S, Wickline SA, Efimov IR, Marian AJ, Circulation 2009 119 1398 1407 10.1161/CIRCULATIONAHA.108.790501 19255346
23. Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation. Marian AJ, Senthil V, Chen SN, Lombardi R, J Am Coll Cardiol 2006 47 827 834 10.1016/j.jacc.2005.10.041 16487852 (Pubitemid 43243108)
24. Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade. Jones ES, Black MJ, Widdop RE, J Mol Cell Cardiol 2004 37 1023 1030 10.1016/j.yjmcc.2004.08.004 15522279 (Pubitemid 39446827)
25. T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA. Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA, J Cardiovasc Magn Reson 2012 14 26 10.1186/1532-429X-14-26 22540153
26. Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. Messroghli DR, Greiser A, Frohlich M, Dietz R, Schulz-Menger J, J Magn Reson Imaging 2007 26 1081 1086 10.1002/jmri.21119 17896383 (Pubitemid 47548170)
27. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Kellman P, Arai AE, McVeigh ER, Aletras AH, Magn Reson Med 2002 47 372 383 10.1002/mrm.10051 11810682 (Pubitemid 34116807)
28. An open-source software tool for the generation of relaxation time maps in magnetic resonance imaging. Messroghli DR, Rudolph A, Abdel-Aty H, Wassmuth R, Kuhne T, Dietz R, Schulz-Menger J, BMC Med Imaging 2010 10 16 10.1186/1471-2342-10-16 20673350
29. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, et al. Circulation 2002 105 539 542 10.1161/hc0402.102975 11815441 (Pubitemid 34262671)
30. Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution-reproducibility study. Messroghli DR, Plein S, Higgins DM, Walters K, Jones TR, Ridgway JP, Sivananthan MU, Radiology 2006 238 1004 1012 10.1148/radiol.2382041903 16424239 (Pubitemid 43289933)
31. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, Pennell DJ, Am J Cardiol 2002 90 29 34 10.1016/S0002-9149(02)02381-0 12088775 (Pubitemid 34671198)
32. Machin D, Campbell M, Fayers P, Pinol A, Sample Size Tables for Clinical Studies Malden, MA: Blackwell Science 2nd 1997
33. Altman DG, Practical Statistics for Medical Research London: Chapman and Hall 1990 440
34. T1 Mapping in Cardiomyopathy at Cardiac MR: Comparison with Endomyocardial Biopsy. Sibley CT, Noureldin RA, Gai N, Nacif MS, Liu S, Turkbey EB, Mudd JO, van der Geest RJ, Lima JA, Halushka MK, Bluemke DA, Radiology 2012 265 724 732 10.1148/radiol.12112721 23091172
35. Assessment of Diffuse Myocardial Fibrosis in Rats Using Small Animal Look-Locker Inversion Recovery (SALLI) T1 Mapping. Messroghli D, Nordmeyer S, Dietrich T, Dirsch O, Kaschina E, Savvatis K, OHI D, Klein C, Berger F, Kuehne T, Circ Cardiovasc Imaging 2011 4 636 640 10.1161/CIRCIMAGING.111.966796 21917782
36. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Tsutsumi Y, Matsubara H, Ohkubo N, Mori Y, Nozawa Y, Murasawa S, Kijima K, Maruyama K, Masaki H, Moriguchi Y, et al. Circ Res 1998 83 1035 1046 10.1161/01.RES.83.10.1035 9815151 (Pubitemid 28520933)
37. Coronary hemodynamic and ventricular responses to angiotensin type 1 receptor inhibition in SHR: interaction with angiotensin type 2 receptors. Varagic J, Susic D, Frohlich ED, Hypertension 2001 37 1399 1403 10.1161/01.HYP.37.6.1399 11408384 (Pubitemid 34225381)
38. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM, Circulation 1999 100 1992 2002 10.1161/01.CIR.100.19.1992 10556226 (Pubitemid 29529292)
39. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ, Eur Heart J 2005 26 1461 1474 10.1093/eurheartj/ehi258 15831557 (Pubitemid 41373486)
40. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Judd RM, Lugo-Olivieri CH, Arai M, Kondo T, Croisille P, Lima JA, Mohan V, Becker LC, Zerhouni EA, Circulation 1995 92 1902 1910 10.1161/01.CIR.92.7.1902 7671375
41. T1 mapping shows increased extracellular matrix size in the myocardium due to amyloid depositions. Robbers LF, Baars EN, Brouwer WP, Beek AM, Hofman MB, Niessen HW, van Rossum AC, Marcu CB, Circ Cardiovasc Imaging 2012 5 423 426 10.1161/CIRCIMAGING.112.973438 22592012
42. Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Bottini PB, Carr AA, Prisant LM, Flickinger FW, Allison JD, Gottdiener JS, Am J Hypertens 1995 8 221 228 10.1016/0895-7061(94)00178-E 7794570
43. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. Flett AS, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C, Muthurangu V, Moon JC, JACC Cardiovasc Imaging 2011 4 150 156 10.1016/j.jcmg.2010.11.015 21329899
44. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP, Magn Reson Med 2004 52 141 146 10.1002/mrm.20110 15236377 (Pubitemid 39295266)
45. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. Piechnik SK, Ferreira VM, Dall'Armellina E, Cochlin LE, Greiser A, Neubauer S, Robson MD, J Cardiovasc Magn Reson 2010 12 69 10.1186/1532-429X-12-69 21092095
46. Motion correction for myocardial T1 mapping using image registration with synthetic image estimation. Xue H, Shah S, Greiser A, Guetter C, Littmann A, Jolly MP, Arai AE, Zuehlsdorff S, Guehring J, Kellman P, Magn Reson Med 2012 67 1644 1655 10.1002/mrm.23153 22135227
47. Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. Sasaki M, Yamada K, Watanabe Y, Matsui M, Ida M, Fujiwara S, Shibata E, Acute Stroke Imaging Standardization Group-Japan I, Radiology 2008 249 624 630 10.1148/radiol.2492071681 18936317